Differential regulation of cytokine production by nitric oxide - PubMed (original) (raw)

Differential regulation of cytokine production by nitric oxide

J Marcinkiewicz et al. Immunology. 1993 Sep.

Abstract

Nitric oxide (NO) has recently been identified as a potent and pleiotropic intracellular mediator produced by and acting on many cells of the body. Although considerable attention has been devoted to the regulation of NO by inflammatory cytokines, and also to the role of NO as an important effector molecule in immune function, there is very little information on the role of this mediator in modulating T-cell-dependent cytokine production. In this study we show that physiological levels of NO (either produced by activated macrophages or by the addition of exogenous NO donors) can selectively down-regulate interleukin-3 (IL-3) production by spleen cells from contact-sensitized mice, while leaving IL-2 activity unaffected. Thus NO may have an important role as an immunomodulatory as well as effector molecule in the immune system.

PubMed Disclaimer

Similar articles

• Differential cytokine regulation by eicosanoids in T cells primed by contact sensitisation with TNP.
  Marcinkiewicz J, Chain BM. Marcinkiewicz J, et al. Cell Immunol. 1993 Jul;149(2):303-14. doi: 10.1006/cimm.1993.1157. Cell Immunol. 1993. PMID: 7687200
• Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages.
  Marcinkiewicz J, Grabowska A, Chain B. Marcinkiewicz J, et al. Eur J Immunol. 1995 Apr;25(4):947-51. doi: 10.1002/eji.1830250414. Eur J Immunol. 1995. PMID: 7737298
• In vitro and in vivo effects of mercuric chloride on thymic endocrine activity, NK and NKT cell cytotoxicity, cytokine profiles (IL-2, IFN-gamma, IL-6): role of the nitric oxide-L-arginine pathway.
  Santarelli L, Bracci M, Mocchegiani E. Santarelli L, et al. Int Immunopharmacol. 2006 Mar;6(3):376-89. doi: 10.1016/j.intimp.2005.08.028. Epub 2005 Nov 9. Int Immunopharmacol. 2006. PMID: 16428073
• Macrophages in mice acutely infected with lymphocytic choriomeningitis virus are primed for nitric oxide synthesis.
  Butz EA, Hostager BS, Southern PJ. Butz EA, et al. Microb Pathog. 1994 Apr;16(4):283-95. doi: 10.1006/mpat.1994.1029. Microb Pathog. 1994. PMID: 7968457
• Regulation of cytokine production by eicosanoids and nitric oxide.
  Marcinkiewicz J. Marcinkiewicz J. Arch Immunol Ther Exp (Warsz). 1997;45(2-3):163-7. Arch Immunol Ther Exp (Warsz). 1997. PMID: 9597082 Review.

Cited by

• Immunotoxicity of zinc oxide nanoparticles with different size and electrostatic charge.
  Kim CS, Nguyen HD, Ignacio RM, Kim JH, Cho HC, Maeng EH, Kim YR, Kim MK, Park BK, Kim SK. Kim CS, et al. Int J Nanomedicine. 2014 Dec 15;9 Suppl 2(Suppl 2):195-205. doi: 10.2147/IJN.S57935. eCollection 2014. Int J Nanomedicine. 2014. PMID: 25565837 Free PMC article.
• Staphylococcal enterotoxin A acts through nitric oxide synthase mechanisms in human peripheral blood mononuclear cells to stimulate synthesis of pyrogenic cytokines.
  Won SJ, Huang WT, Lai YS, Lin MT. Won SJ, et al. Infect Immun. 2000 Apr;68(4):2003-8. doi: 10.1128/IAI.68.4.2003-2008.2000. Infect Immun. 2000. PMID: 10722595 Free PMC article.
• The involvement of nitric oxide in a mouse model of adult respiratory distress syndrome.
  Pheng LH, Francoeur C, Denis M. Pheng LH, et al. Inflammation. 1995 Oct;19(5):599-610. doi: 10.1007/BF01539139. Inflammation. 1995. PMID: 8543374
• Control of Orthodontic Tooth Movement by Nitric Oxide Releasing Nanoparticles in Sprague-Dawley Rats.
  Crawford D, Lau TC, Frost MC, Hatch NE. Crawford D, et al. Front Dent Med. 2022 Apr;9:811251. doi: 10.3389/fmats.2022.811251. Epub 2022 Apr 14. Front Dent Med. 2022. PMID: 36081866 Free PMC article.
• Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells.
  Bauer H, Jung T, Tsikas D, Stichtenoth DO, Frölich JC, Neumann C. Bauer H, et al. Immunology. 1997 Feb;90(2):205-11. doi: 10.1046/j.1365-2567.1997.00161.x. Immunology. 1997. PMID: 9135548 Free PMC article.

References

1. 1. Nature. 1987 Jun 11-17;327(6122):524-6 - PubMed
2. 1. Br J Pharmacol. 1992 Nov;107(3):745-9 - PubMed
3. 1. Biochemistry. 1988 Nov 29;27(24):8706-11 - PubMed
4. 1. Biochem Pharmacol. 1989 Jun 1;38(11):1709-15 - PubMed
5. 1. Eur J Immunol. 1989 Jul;19(7):1227-32 - PubMed

Publication types

MeSH terms

Substances